Binding of 8-mer to 11-mer peptides carrying the anchor residues to slow assembling HLA class I molecules (HLA-B*5101)

Immunogenetics

Volumn 45, Issue 4, 1997, Pages 259-265

  Sakaguchi, Takashi ^a,c   Ibe, Masaaki ^a   Miwa, Kiyoshi ^b   Kaneko, Yutaro ^b   Yokota, Shumpei ^c   Tanaka, Katsuaki ^c   Takiguchi, Masafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AJINOMOTO CO INC   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCINE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; LEUCINE; METHIONINE; PROLINE; VALINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

CELL LINE; HEPACIVIRUS; HIV-1; HLA-B ANTIGENS; HUMANS; PEPTIDES; PROTEIN BINDING; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE; TIME FACTORS; VIRAL PROTEINS;

ANIMALIA;

EID: 0031054045     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050201     Document Type: Article

References (28)

1. Baricordi, O. R., Sensi, A., Pivettipezzi, P., Perrone, S., Balboni, A., Catarinelli, G., Filippi, F., Melchiorri, L., Moncada, A., and Mattiuz, P. L. Behçet's disease associated with HLA-B51 and DRw52 antigens in Italians. Hum Immunol 17: 297-301, 1986
2. Collins, E. J., Garboczi, D. N., and Willey, D. C. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature 371: 626-629, 1994
3. D'Urso, C. M., Wang, Z., Cao, Y., Tatake, R., Zeff, R. A., and Ferrone, S. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in β2m gene expression. J Clin Invest 87: 284-292, 1991
4. Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351: 290-296, 1991
5. Falk, K., Rötzschke, O., Grahovac, B., Schendel, D., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics 38: 161-162, 1993
6. Falk, K., Rötzschke, O., Takiguchi, M., Grahovac, B., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-A1, -A11, -A31 and -A33 molecules. Immunogenetics 40: 238-241, 1994
7. Falk, K., Rötzschke, O., Takiguchi, M., Gnau, V., Stevanović, S., Jung, G., and Rammensee, H.-G. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behçet's disease. Int Immunol 7: 223-228, 1995
8. Guo, H.-C., Jardetzky, T. S., Garrett, T. P. J., Lane, W. S., Strominger, J. L., and Willey, D. C. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360: 364-366, 1992
9. Hayashi, H., Ennis, P. D., Ariga, H., Salter, R. D., Parham, P., Kano, K., and Takiguchi, M. HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the α1 domain. J Immunol 142: 306-311, 1989
10. Hill, A., Takiguchi, M., and McMichael, A. Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the α2 domain. Immunogenetics 37: 95-101, 1993
11. Jardetzky, T. S., Lane, W. S., Robinson, R. A., Madden, D. R., and Wiley, D. C. Identification of self peptides bound to purified HLA-B27. Nature 353: 326-329, 1991
12. Kikuchi, A., Sakaguchi, T., Miwa, K., Takamiya, Y., Rammensee, H.-G., Kaneko, Y., and Takiguchi, M. Binding of nonamer peptides to three HLA-B51 molecules which differ by a single amino acid substitution in the A-pocket. Immunogenetics 43: 268-276, 1996
13. Koziel, M. J., Dudley, D., Afdhal, N., Choo, Q.-L., Houghton, M., Ralston, R., and Walker, B. D. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 67: 7522-7532, 1993
14. Matsumoto, K., Yamamoto, J., Hiraiwa, M., Kano, K., and Takiguchi, M. Discrimination of HLA-B5 crossreactive group antigens by human allospecific CTL clones. Transplantation 49: 1164-1167, 1990
15. Nakayama, S., Kawaguchi, G., Karaki, S., Nagao, T., Uchida, H., Kashiwase, K., Akaza, T., Nasuno, T., and Takiguchi, M. Effect of single amino acid substitution at residue 167 of HLA-B51 on binding of antibodies and recognition of T cells. Hum Immunol 39: 211-219, 1994
16. Nokihara, K., Yamamoto, R., Hazama, M., Wakizawa, O., and Nakamura, S. Design and applications of a novel simultaneous multiple solid-phase peptide synthesizer. In R. Epton (ed.): Innovation and Perspectives in Solid-Phase synthesis, p 445. Intercept, Andover, 1992
17. Ohno, S., Aoki, K., Sugiura, S., Nakajima, E., Itakura, K., and Aizawa, M. HL-A5 and Behçet's disease. Lancet 2: 1383-1384, 1973
18. Ohno, S., Asanuma, T., Sugiura, S., Wakisaka, A., and Aizawa, M. HLA-Bw51 and Behçet's disease. J Am Med Assoc 240: 529, 1978
19. Ooba, T., Hayashi, H., Karaki, S., Tanabe, M., Kano, K., and Takiguchi, M., The structure of HLA-B35 suggests that it is derived from HLA-Bw58 by two genetic mechanisms. Immunogenetics 30: 76-80, 1989
20. Parker, K. C., Bednarek, M. A., Hull, L. K., Cunningham, Y., Utz, B., Zweerink, H. J., Biddison, W. E., and Coligan, J. E. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J Immunol 149: 3580-3587, 1992
21. Parker, K. C., Bednarek, M. A., and Coligan, J. E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152: 163-175, 1994
22. Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., and Sette, A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74: 929-937, 1993
23. Schönbach, C., Ibe, M., Shiga, H., Takamiya, Y., Miwa, K., Nokihara, K., and Takiguchi, M. Fine turning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J Immunol 154: 5951-5958, 1995
24. Schönbach, C., Miwa, K., Ibe, M., Shiga, H., Nokihara, K., Takiguchi, M. Refined peptide-HLA-B*3501 binding motif reveals differences in 9-mer to 11-mer peptide binding. Immunogenetics 45: 121-129, 1996
25. Takamiya, Y., Schönbach, C., Nokihara, K., Ferrone, S., Yamaguchi, M., Kano, K., Egawa, K., and Takiguchi, M. HLA-B*3501-peptide interactions: Role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int Immunol 6: 255-261, 1994
26. Tait, B. D., Naito, S., Boyle, A., Dupont, E., Andrien, M., Saitou, S., Miller, S., Scorza, R., Kalil, J., Grumet, C., Pitchappau, R. M., Bias, W., Cantwell, L., Bennett, G., Zachary, A., Garrido, F., and Maeda, H. Antigen Society no. 105: HLA-B5, -B51, -B52, -B18, -B35, -B53. In K. Tsuji, M. Aizawa, and T. Sasazuki (eds.): HLA 1991, pp. 297-305. Oxford Science Publications, Oxford. 1992
27. Tanabe, M., Sekimata, M., Ferrone, S., and Takiguchi, M. Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 148: 3202-3209, 1992
28. Udaka, K., Wiesmüller, K.-H., Kienle, S., Jung, G., and Walden, P. Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries. J Exp Med 181: 2097-2108, 1995